ACCESS Newswire
15 Aug 2022, 00:31 GMT+10
NEW YORK, NY / ACCESSWIRE / August 14, 2022 / Pomerantz LLP is investigating claims on behalf of investors of Phathom Pharmaceuticals, Inc. ('Phathom' or the 'Company') (NASDAQ: PHAT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether Phathom and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On or around October 24, 2019, Phathom conducted its initial public offering ('IPO'), selling almost 11 million shares of common stock priced at $19.00 per share. Then, on August 2, 2022, Phathom issued a press release announcing its financial results for the second quarter of 2022 and providing a business update. The Company reported GAAP earnings per share of -$1.33, missing consensus estimates by $0.30. Phathom also advised investors of 'a delay of the planned VOQUEZNA DUAL PAK and VOQUEZNA TRIPLE PAK product launches' after 'tests revealed trace levels of a nitrosamine impurity' in the product.
On this news, Phathom's stock price fell $2.61 per share, or 28.78%, to close at $6.46 per share on August 2, 2022.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
SOURCE: Pomerantz LLP
Get a daily dose of Chicago Chronicle news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Chicago Chronicle.
More InformationWASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...
BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...
NEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...
LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
(Photo credit: Kamil Krzaczynski-Imagn Images) As the 2025 WNBA season approaches its All-Star weekend, the Minnesota Lynx head to...
(Photo credit: Stan Szeto-Imagn Images) If you enjoy racing at NASCAR's snaking road courses, you have come to the right place over...
(Photo credit: Brad Penner-Imagn Images) New York Yankees left-hander Carlos Rodon was named to the American League All-Star team...
(Photo credit: Anne-Marie Sorvin-Imagn Images) It's been more than a month since San Diego FC needed to bounce back from a defeat....
(Photo credit: David Reginek-Imagn Images) Left-handed reliever Fraser Ellard returned to the Chicago White Sox for Friday's doubleheader...